# Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

> **NCT07487623** · NA · RECRUITING · sponsor: **University of Guadalajara** · enrollment: 26 (estimated)

## Conditions studied

- Liver Disease Chronic
- HEPATITIS C VIRUS CHRONIC INFECTION

## Interventions

- **DIETARY_SUPPLEMENT:** resveratrol, quercetin, taurine, whey protein, and inulin
- **DIETARY_SUPPLEMENT:** whey protein

## Key facts

- **NCT ID:** NCT07487623
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-11
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-05-15
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07487623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07487623, "Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07487623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*